Clinical trials
Enrolling by invitation Antiphospholipid Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bioray Laboratories | 1 |
| Chinese University of Hong Kong | 1 |
| Chugai Pharmaceutical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Antiphospholipid Syndrome | 3 |
| Behcet Syndrome | 1 |
| Constriction, Pathologic | 1 |
| Dermatomyositis | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Myositis | 1 |
| Pemphigoid, Bullous | 1 |
| Purpura, Thrombocytopenic, Idiopathic | 1 |
| Scleroderma, Systemic | 1 |
| Sjogren's Syndrome | 1 |
Trials
Showing 26 to 3 of 3. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.